Prime Medicine PRME Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Intellia TherapeuticsNTLA

$73.41M-28.4%

Sana BiotechnologySANA

$75.33M-17.5%

MeiraGTx Holdings plcMGTX

$12.83M+73.8%

OnKure Therapeutics, Inc.OKUR

$409K-57.2%

FAQ

What is Prime Medicine's operating lease liabilities (total)?

Prime Medicine (PRME) reported operating lease liabilities (total) of $112.48M in Q2 2026.

How has Prime Medicine's operating lease liabilities (total) changed year-over-year?

Prime Medicine's operating lease liabilities (total) decreased by 6.1% year-over-year, from $119.74M to $112.48M.

What is the long-term trend for Prime Medicine's operating lease liabilities (total)?

Over 4 years (2020 to 2025), Prime Medicine's operating lease liabilities (total) has grown at a 156.3% compound annual growth rate (CAGR), from $2.7M to $116.43M.

What does operating lease liabilities (total) mean?

This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.